Log in or Sign up for Free to view tailored content for your specialty!
Wound Management News
Patients with Buruli ulcer benefit by delaying surgery decision
Study findings suggest that patients being treated for Buruli ulcer benefit from delaying the decision of whether to undergo excision surgery, once the main treatment option for the often debilitating neglected tropical disease, researchers said.
Short-course AmBisome effective against persistent leishmaniasis
A 15-mg/kg dose of AmBisome given over 15 days in five biweekly infusions was safe and effective against post-kala-azar dermal leishmaniasis, or PKDL, a condition in which Leishmania parasites persist despite successful visceral leishmaniasis treatment, according to researchers.
Log in or Sign up for Free to view tailored content for your specialty!
Ceramide-infused skin barrier reduces costs, complications in ostomy care
Using an ostomy skin barrier infused with ceramide resulted in lower costs and improved satisfaction for patients, according to a study published in the Journal of Wound, Continence and Ostomy Nursing.
GI, respiratory, skin disease top list among troops in Ebola response
SAN DIEGO — Complaints of upper respiratory, gastrointestinal and skin disease symptoms accounted for the majority of clinical visits by United States military personnel during their response to the 2014 Ebola virus outbreak in West Africa, according to researchers.
Erosive pustular dermatosis may occur after facial trauma, cosmetic resurfacing
A recent case series elucidated several clinical factors and treatment options for erosive pustular disorder.
New data support efficacy of GEN-003 vaccine against genital lesions
Recent 12-month data from a phase 2b trial demonstrated that Genocea Biosciences’ lead GEN-003 vaccine regimen reduced the median rate of genital lesions by nearly 50% compared with placebo among patients with herpes simplex virus-2.
Top five dermatology stories in July include psoriasis studies, FDA approval
Study results reporting that nail findings distinguished patients with psoriatic arthritis from those with psoriasis without arthritis was among the top read articles in July on Healio.com/Dermatology.
Oral ABSSSI treatment omadacycline meets primary endpoints in phase 3 trial
Paratek Pharmaceuticals recently announced that its investigational antibiotic omadacycline — a once-daily, oral treatment for acute bacterial skin and skin structure infections, or ABSSSIs — met all primary and secondary endpoints specified by the FDA and European Medicines Agency in a recent phase 3 study that compared the safety and efficacy of the drug with twice-daily Zyvox.
Bullous pemphigoid showed possible link to hematologic malignancy
Bullous pemphigoid demonstrated some association with hematologic malignancy despite showing no association with overall malignancy.
Adjunctive antibiotic therapy improves cure rates for simple skin abscesses
Another study has shown the clinical benefit of adding antibiotic therapy to incision and drainage treatment for uncomplicated skin abscesses.
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read